Biocon's Covid-19 Drug Itolizumab Approved for Emergency Use after Trial on Only 30 Patients - Latest News

    • Breaking

    Home Top Ad

    Responsive Ads Here

    Post Top Ad

    Responsive Ads Here

    Monday, July 13, 2020

    Home Latest News Biocon's Covid-19 Drug Itolizumab Approved for Emergency Use after Trial on Only 30 Patients

    Biocon's Covid-19 Drug Itolizumab Approved for Emergency Use after Trial on Only 30 Patients

    Itolizumab is an existing drug used to treat skin ailment Psoriasis. The Drug Controller General of India (DCGI) approved its restricted emergency use on Saturday.

    from Top India News- News18.com https://ift.tt/32dxt1A
    https://ift.tt/2Y6XZY6
    Tags
    Share This
    Author Image

    About reviews by mpr

    Posted by: at
    Tags:

    No comments:

    Post a Comment

    Subscribe to: Post Comments (Atom)

    Post Bottom Ad

    Responsive Ads Here

    Author Details

    Templatesyard is a blogger resources site is a provider of high quality blogger template with premium looking layout and robust design. The main mission of templatesyard is to provide the best quality blogger templates which are professionally designed and perfectlly seo optimized to deliver best result for your blog.

    Pages